• Fund Type: Closed-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

BB Biotech AG

+ Add to Watchlist

BION:SW

218.8000 CHF 2.4000 1.11%

As of 11:33:42 ET on 11/21/2014.

Snapshot for BB Biotech AG (BION)

Open: 218.0000 High - Low: 220.3000 - 217.0000 Primary Exchange: SIX Swiss Ex
Volume: 42,488 52-Week Range: 124.5100 - 220.3000 Beta vs NBI: 0.8617

ETF Chart for BION

No chart data available.
  • BION:SW 218.8000
  • 1D
  • 1M
  • 1Y
216.4000
Interactive BION Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BION

BB Biotech AG is an investment company. The Company invests in biotech companies that operate in areas that include oncology, cardiovascular diseases, infectious diseases and autoimmune diseases.

Inception Date: 1993-11-16 Telephone: Tel: +41 44 267 67 00
Managers: DANIEL KOLLER
Web Site: www.bbbiotech.ch

Fundamentals for BION

NAV (on 2014-11-20) 280.6000
Assets (M) (on 2002-12-31) 1,579.0000
Shares out (M) 11.85
Market Cap (M) 2,592.78
% Premium -22.88
Average 52-Week % Premium -22.0370
Fund Leveraged N

Dividends for BION

Dividend Type Return of Capital
Dividend Frequency Annual
Last Dividend Net (on 2014-03-21) 7.0000
Dividend Yield (ttm) 3.20%

Performance for BION

1-Month +20.15% 1-Year +67.47%
3-Month +31.65% 3-Year +61.99%
Year To Date +62.36% 5-Year +28.56%
Expense Ratio 1.69

Top Fund Holdings for BION

Filing Date: 09/30/2014
Name Position Value % of Total
Celgene Corp 3,889,298 351,900,000 12.694%
Gilead Sciences Inc 2,795,596 284,100,000 10.248%
Actelion Ltd 2,377,238 267,000,000 9.632%
Isis Pharmaceuticals Inc 6,636,526 246,000,000 8.874%
Incyte Corp 4,301,867 201,400,000 7.265%
Vertex Pharmaceuticals Inc 1,354,445 145,200,000 5.238%
Medivation Inc 1,429,706 135,000,000 4.870%
Alexion Pharmaceuticals Inc 727,428 115,200,000 4.156%
Agios Pharmaceuticals Inc 1,890,521 110,700,000 3.993%
Puma Biotechnology Inc 476,991 108,600,000 3.918%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil